HDClarity is currently under review in the UK, Germany and Canada. The protocol and information are being considered by research ethics review boards. If the review is favourable, we will soon start enrolling sites in these countries and collecting samples.
A multi-site cerebrospinal fluid collection initiative to facilitate therapeutic development for Huntington’s disease.